BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marom EM, Aloia TA, Moore MB, Hara M, Herndon JE, Harpole DH, Goodman PC, Patz EF. Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. Lung Cancer. 2001;33:99-107. [PMID: 11551404 DOI: 10.1016/s0169-5002(00)00250-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Hong R, Lim SC. 18F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma. World J Gastroenterol 2012; 18(2): 168-174 [PMID: 22253523 DOI: 10.3748/wjg.v18.i2.168] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
2 Ayala FR, Rocha RM, Carvalho KC, Carvalho AL, da Cunha IW, Lourenço SV, Soares FA. GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma. Molecules 2010;15:2374-87. [PMID: 20428049 DOI: 10.3390/molecules15042374] [Cited by in Crossref: 92] [Cited by in F6Publishing: 89] [Article Influence: 8.4] [Reference Citation Analysis]
3 Turcotte E, Leblanc M, Carpentier A, Bénard F. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-D: -glucose Injection following I.V. Insulin in diabetic patients. Mol Imaging Biol. 2006;8:348-354. [PMID: 17053859 DOI: 10.1007/s11307-006-0064-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
4 Voelxen NF, Blatt S, Knopf P, Henkel M, Appelhans C, Righesso LAR, Pabst A, Goldschmitt J, Walenta S, Neff A, Mueller-Klieser W, Ziebart T. Comparative metabolic analysis in head and neck cancer and the normal gingiva. Clin Oral Investig 2018;22:1033-43. [PMID: 28735466 DOI: 10.1007/s00784-017-2185-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
5 Goodwin J, Neugent ML, Lee SY, Choe JH, Choi H, Jenkins DMR, Ruthenborg RJ, Robinson MW, Jeong JY, Wake M, Abe H, Takeda N, Endo H, Inoue M, Xuan Z, Yoo H, Chen M, Ahn JM, Minna JD, Helke KL, Singh PK, Shackelford DB, Kim JW. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nat Commun 2017;8:15503. [PMID: 28548087 DOI: 10.1038/ncomms15503] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 15.0] [Reference Citation Analysis]
6 Oh DY, Kim JW, Koh SJ, Kim M, Park JH, Cho SY, Kim BG, Lee KL, Im JP. Does diabetes mellitus influence standardized uptake values of fluorodeoxyglucose positron emission tomography in colorectal cancer? Intest Res 2014;12:146-52. [PMID: 25349582 DOI: 10.5217/ir.2014.12.2.146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
7 Gentles AJ, Bratman SV, Lee LJ, Harris JP, Feng W, Nair RV, Shultz DB, Nair VS, Hoang CD, West RB, Plevritis SK, Alizadeh AA, Diehn M. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. J Natl Cancer Inst 2015;107:djv211. [PMID: 26286589 DOI: 10.1093/jnci/djv211] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
8 Alvarez JV, Belka GK, Pan TC, Chen CC, Blankemeyer E, Alavi A, Karp JS, Chodosh LA. Oncogene pathway activation in mammary tumors dictates FDG-PET uptake. Cancer Res. 2014;74:7583-7598. [PMID: 25239452 DOI: 10.1158/0008-5472.can-14-1235] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 6.7] [Reference Citation Analysis]
9 O'Neill H, Malik V, Johnston C, Reynolds JV, O'Sullivan J. Can the Efficacy of [18F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles? Pharmaceuticals (Basel) 2019;12:E16. [PMID: 30678034 DOI: 10.3390/ph12010016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Kumar D. Regulation of glycolysis in head and neck squamous cell carcinoma. Postdoc J 2017;5:14-28. [PMID: 28191478 DOI: 10.14304/surya.jpr.v5n1.4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
11 Nair VS, Gevaert O, Davidzon G, Plevritis SK, West R. NF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism. Lung Cancer. 2014;83:189-196. [PMID: 24355259 DOI: 10.1016/j.lungcan.2013.11.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
12 Heiden BT, Chen G, Hermann M, Brown RKJ, Orringer MB, Lin J, Chang AC, Carrott PW, Lynch WR, Zhao L, Beer DG, Reddy RM. 18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer. PLoS One 2018;13:e0199970. [PMID: 29966011 DOI: 10.1371/journal.pone.0199970] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
13 Ono K, Takigawa S, Yamada K. L-Glucose: Another Path to Cancer Cells. Cancers (Basel) 2020;12:E850. [PMID: 32244695 DOI: 10.3390/cancers12040850] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Meyer HJ, Wienke A, Surov A. Associations between GLUT expression and SUV values derived from FDG-PET in different tumors-A systematic review and meta analysis. PLoS One 2019;14:e0217781. [PMID: 31206524 DOI: 10.1371/journal.pone.0217781] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
15 Calvaresi EC, Hergenrother PJ. Glucose conjugation for the specific targeting and treatment of cancer. Chem Sci. 2013;4:2319-2333. [PMID: 24077675 DOI: 10.1039/c3sc22205e] [Cited by in Crossref: 211] [Cited by in F6Publishing: 184] [Article Influence: 26.4] [Reference Citation Analysis]
16 Jadvar H, Alavi A, Gambhir SS. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med 2009;50:1820-7. [PMID: 19837767 DOI: 10.2967/jnumed.108.054098] [Cited by in Crossref: 154] [Cited by in F6Publishing: 142] [Article Influence: 12.8] [Reference Citation Analysis]
17 Lee SY, Jee WH, Yoo IR, Jung JY, Im SA, Chung YG, Kang JH. Comparison of 3T diffusion-weighted MRI and 18F-FDG PET/CT in musculoskeletal tumours: quantitative analysis of apparent diffusion coefficients and standardized uptake values. Br J Radiol 2019;92:20181051. [PMID: 31322913 DOI: 10.1259/bjr.20181051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Yang W, Zhang Y, Fu Z, Yu J, Sun X, Mu D, Han A. Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2010;37:1291-1299. [PMID: 20309686 DOI: 10.1007/s00259-010-1412-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
19 Choe JH, Mazambani S, Kim TH, Kim JW. Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas. Cells 2021;10:606. [PMID: 33803326 DOI: 10.3390/cells10030606] [Reference Citation Analysis]
20 Usuda K, Sagawa M, Aikawa H, Ueno M, Tanaka M, Machida Y, Zhao XT, Ueda Y, Higashi K, Sakuma T. Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer. Gen Thorac Cardiovasc Surg. 2010;58:405-410. [PMID: 20703861 DOI: 10.1007/s11748-010-0603-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]